Literature DB >> 16910290

Hyperbaric oxygen therapy after failure of conventional therapy for sudden deafness.

C Desloovere1, R Knecht, P Germonpré.   

Abstract

PROBLEMS/
OBJECTIVES: We investigated the effect of secondary hyperbaric oxygen therapy (HBO) for patients with idiopathic sudden sensorineural hearing loss after unsuccessful conventional treatment.
METHODOLOGY: We retrospectively evaluated 3 groups: 100 patients without further treatment (group 1), 160 patients with secondary HBO at 1.5 ATA (group 2), and 56 patients with secondary HBO at 2.5 ATA (group 3).
RESULTS: In group 1, a mean hearing gain (MHG) of 2.6 +/- 15 dB was found at the end of the follow-up period. After HBO, a MHG of 3.1 +/- 9 dB in group 2 and 19.7 +/- 23 dB in group 3 was achieved. The results in group 3 were statistically significant in comparison to group 1 (p < 0.007) and to group 2 (p < 0.009). With HBO after initial therapy failure, there is a significant correlation of MHG with time delay before HBO (p < 0.03).
CONCLUSIONS: HBO at 2.5 ATA in patients with idiopathic sudden sensorineural hearing loss after unsuccessful conventional treatment yields significant improvement of hearing. MHG is higher when time delay before HBO is shorter.

Entities:  

Mesh:

Year:  2006        PMID: 16910290

Source DB:  PubMed          Journal:  B-ENT        ISSN: 1781-782X            Impact factor:   0.082


  8 in total

1.  Addition of Hyperbaric Oxygen Therapy vs Medical Therapy Alone for Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.

Authors:  Tae-Min Rhee; Doyeon Hwang; Jee-Soo Lee; Jonghanne Park; Joo Myung Lee
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-12-01       Impact factor: 6.223

2.  Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: a prospective controlled study.

Authors:  M Pezzoli; M Magnano; L Maffi; L Pezzoli; P Marcato; M Orione; D Cupi; G Bongioannini
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-16       Impact factor: 2.503

3.  Effects of topical nasal steroids and diclofenac on the nasal mucosa during hyperbaric oxygen therapy: a double-blind experimental study.

Authors:  Erkan Vuralkan; Hatice Bengu Cobanoglu; Abdullah Arslan; Selcuk Arslan; Sevdegul Mungan; Selcuk Tatar; Akın Savas Toklu
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-22       Impact factor: 2.503

4.  Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities.

Authors:  Ahmed Khater; Mohammad Waheed El-Anwar; Ahmad Abdel-Fattah Nofal; Atef Taha Elbahrawy
Journal:  Int Arch Otorhinolaryngol       Date:  2017-09-12

5.  The effectiveness of hyperbaric oxygen in patients with idiopathic sudden sensorineural hearing loss: a systematic review.

Authors:  Burak Eryigit; Fuat Ziylan; Furkan Yaz; Hans G X M Thomeer
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-10-15       Impact factor: 2.503

Review 6.  The use of hyperbaric oxygen therapy in acute hearing loss: a narrative review.

Authors:  A B Bayoumy; J A de Ru
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-20       Impact factor: 2.503

7.  Comparison of Different Treatment Methods for Idiopathic Sudden Sensorineural Hearing Loss.

Authors:  Tolgahan Toroslu; Halil Erdoğan; Özge Çağlar; Oğuz Güçlü; Fevzi Sefa Dereköy
Journal:  Turk Arch Otorhinolaryngol       Date:  2018-12-21

8.  Intratympanic steroid injection and hyperbaric oxygen therapy for the treatment of refractory sudden hearing loss.

Authors:  Filiz Gülüstan; Zahide Mine Yazıcı; Wesam M E Alakhras; Omer Erdur; Harun Acipayam; Levent Kufeciler; Fatma Tulin Kayhan
Journal:  Braz J Otorhinolaryngol       Date:  2016-11-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.